Cancer incidence in the United Kingdom: projections to the year 2030

被引:199
|
作者
Mistry, M. [1 ]
Parkin, D. M. [1 ]
Ahmad, A. S. [1 ]
Sasieni, P. [1 ]
机构
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Canc Prevent, Wolfson Inst Prevent Med, London EC1M 6BQ, England
关键词
incidence; projections; age-period-cohort models; splines; cancer registration; NORDIC COUNTRIES; FUTURE BURDEN; MORTALITY; ENGLAND; PREDICTION; WALES; UK;
D O I
10.1038/bjc.2011.430
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Projections of cancer incidence are important for planning health services and to provide a baseline for assessing the impact of public health interventions. METHODS: Rates estimated from smooth function age-period-cohort modelling of cancer incidence data from Great Britain 1975 to 2007 are extrapolated to 2030 and applied to UK population projections. Prostate and breast cancer projections take into account the effect of screening. RESULTS: Overall rates of cancer are projected to be stable over the next 20 years, but this masks individual changes. In both sexes, age-standardised rates of cancers of the stomach, larynx, bladder and leukaemia are projected to fall by >= 1% per year, whereas cancers of the lip, mouth and pharynx (ICD-10 C00-C14) and melanoma are projected to increase by >= 1% per year. The growing and aging populations will have a substantial impact: numbers of cancers in men and women are projected to increase by 55% (from 149 169 to 231 026) and 35% (from 148 716 to 200 929), respectively, between 2007 and 2030. The model used yields similar results to those of Nordpred, but is more flexible. CONCLUSION: Without new initiatives for smoking and obesity reduction, the number of cancers in the United Kingdom will increase substantially reflecting the growing and aging populations. British Journal of Cancer (2011) 105, 1795-1803. doi:10.1038/bjc.2011.430 www.bjcancer.com Published online 27 October 2011 (C) 2011 Cancer Research UK
引用
收藏
页码:1795 / 1803
页数:9
相关论文
共 50 条
  • [1] Cancer incidence in the United Kingdom: projections to the year 2030
    M Mistry
    D M Parkin
    A S Ahmad
    P Sasieni
    [J]. British Journal of Cancer, 2011, 105 : 1795 - 1803
  • [2] Comment on ‘cancer incidence in the United Kingdom: projections to the year 2030’
    S E Oliver
    E Roman
    S Crouch
    E Bolton
    B Ferguson
    [J]. British Journal of Cancer, 2013, 108 : 1213 - 1214
  • [3] Comment on 'cancer incidence in the United Kingdom: projections to the year 2030'
    Oliver, S. E.
    Roman, E.
    Crouch, S.
    Bolton, E.
    Ferguson, B.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1213 - 1214
  • [4] Reply to 'Comment on Cancer incidence in the United Kingdom: projections to the year 2030'
    Ahmad, A. S.
    Parkin, D. M.
    Sasieni, P. D.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1215 - 1217
  • [5] Reply to ‘Comment on Cancer incidence in the United Kingdom: projections to the year 2030’
    A S Ahmad
    D M Parkin
    P D Sasieni
    [J]. British Journal of Cancer, 2013, 108 : 1215 - 1217
  • [6] Cancer mortality in the United Kingdom: projections to the year 2025
    A H Olsen
    D M Parkin
    P Sasieni
    [J]. British Journal of Cancer, 2008, 99 : 1549 - 1554
  • [7] Cancer mortality in the United Kingdom: projections to the year 2025
    Olsen, A. H.
    Parkin, D. M.
    Sasieni, P.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 99 (09) : 1549 - 1554
  • [8] Ovarian cancer incidence projections in the United States: Expected increases through 2030.
    Stewart, Sherri L.
    Thompson, Trevor D.
    Weir, Hannah K.
    Rim, Sun Hee
    [J]. CLINICAL CANCER RESEARCH, 2016, 22
  • [9] Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030
    Islam, Jessica Y.
    Rosenberg, Philip S.
    Hall, H. Irene
    Jacobson, Evin U.
    Engels, Eric A.
    Shiels, Meredith S.
    [J]. CANCER RESEARCH, 2017, 77
  • [10] Projections of cancer incidence and cancer-related deaths inGermany by 2020 and 2030
    Quante, Anne S.
    Ming, Chang
    Rottmann, Miriam
    Engel, Jutta
    Boeck, Stefan
    Heinemann, Volker
    Westphalen, Christoph Benedikt
    Strauch, Konstantin
    [J]. CANCER MEDICINE, 2016, 5 (09): : 2649 - 2656